Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Immunologic Factors"" wg kryterium: Temat


Tytuł :
A safety review of biologic therapies for the management of hidradenitis suppurativa and unmet needs.
Autorzy :
Holcomb ZE; Department of Dermatology, Massachusetts General Hospital, Harvard Combined Dermatology Residency Program, Boston, MA, USA.
Porter ML; Clinical Laboratory for Epidemiology and Applied Research in Skin (CLEARS), Department of Dermatology, Beth Israel Deaconess Medical Center, Boston, MA, USA.; Department of Dermatology, Harvard Medical School, Boston, MA, USA.
Kimball AB; Clinical Laboratory for Epidemiology and Applied Research in Skin (CLEARS), Department of Dermatology, Beth Israel Deaconess Medical Center, Boston, MA, USA.; Department of Dermatology, Harvard Medical School, Boston, MA, USA.
Pokaż więcej
Źródło :
Expert opinion on drug safety [Expert Opin Drug Saf] 2021 Oct; Vol. 20 (10), pp. 1147-1161. Date of Electronic Publication: 2021 May 12.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Biological Products/*administration & dosage
Hidradenitis Suppurativa/*drug therapy
Immunologic Factors/*administration & dosage
Adalimumab/administration & dosage ; Adalimumab/adverse effects ; Biological Products/adverse effects ; Biological Therapy/adverse effects ; Biological Therapy/methods ; Health Services Needs and Demand ; Hidradenitis Suppurativa/physiopathology ; Humans ; Immunologic Factors/adverse effects ; Immunologic Factors/pharmacology ; Time Factors
Czasopismo naukowe
Tytuł :
Natural Polyphenols as Immunomodulators to Rescue Immune Response Homeostasis: Quercetin as a Research Model against Severe COVID-19.
Autorzy :
Bernini R; Department of Agriculture and Forest Sciences (DAFNE), University of Tuscia, Via S. Camillo de Lellis, 01100 Viterbo, Italy.
Velotti F; Department of Ecological and Biological Sciences (DEB), University of Tuscia, Largo dell'Università, 01100 Viterbo, Italy.
Pokaż więcej
Źródło :
Molecules (Basel, Switzerland) [Molecules] 2021 Sep 25; Vol. 26 (19). Date of Electronic Publication: 2021 Sep 25.
Typ publikacji :
Journal Article; Review
MeSH Terms :
COVID-19/*drug therapy
Immunologic Factors/*therapeutic use
Polyphenols/*therapeutic use
Quercetin/*therapeutic use
SARS-CoV-2/*drug effects
Adaptive Immunity/drug effects ; Animals ; Antiviral Agents/chemistry ; Antiviral Agents/pharmacology ; Antiviral Agents/therapeutic use ; COVID-19/immunology ; Humans ; Immunity, Innate/drug effects ; Immunologic Factors/chemistry ; Immunologic Factors/pharmacology ; Polyphenols/chemistry ; Polyphenols/pharmacology ; Quercetin/analogs & derivatives ; Quercetin/pharmacology ; SARS-CoV-2/immunology
Czasopismo naukowe
Tytuł :
Beneficial effects and health benefits of Astaxanthin molecules on animal production: A review.
Autorzy :
Raza SHA; College of Animal Science and Technology, Northwest A&F University, Yangling, Shaanxi 712100, PR China. Electronic address: .
Naqvi SRZ; Department of Zoology, Ghazi University, Dera Ghazi Khan 32200, Pakistan.
Abdelnour SA; Animal Production Department, Faculty of Agriculture, Zagazig University, Zagazig 44511, Egypt.
Schreurs N; Animal Science, School of Agriculture and Environment, Massey University, Private Bag 11222, Palmerston North, New Zealand.
Mohammedsaleh ZM; Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, University of Tabuk, Tabuk 71491, Saudi Arabia.
Khan I; State Key Laboratory of Animal Nutrition, Institute of Animal Sciences, Chinese Academy of Agricultural Sciences, Beijing 100193, PR China.
Shater AF; Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, University of Tabuk, Tabuk 71491, Saudi Arabia.
Abd El-Hack ME; Poultry Department, Faculty of Agriculture, Zagazig University, Zagazig 44511, Egypt.
Khafaga AF; Department of Pathology, Faculty of Veterinary Medicine, Alexandria University, Edfina 22758, Egypt.
Quan G; Yunnan Animal Science and Veterinary Institute, Kunming 650224, PR China.
Khan R; Department of Livestock Management, Breeding and Genetics The University of Agriculture Peshawar, Pakistan.
Wang S; College of Animal Science and Technology, Northwest A&F University, Yangling, Shaanxi 712100, PR China.
Cheng G; College of Animal Science and Technology, Northwest A&F University, Yangling, Shaanxi 712100, PR China; National Beef Cattle Improvement Center, Northwest A&F University, 712100 Yangling, Shaanxi, PR China. Electronic address: .
Zan L; College of Animal Science and Technology, Northwest A&F University, Yangling, Shaanxi 712100, PR China; National Beef Cattle Improvement Center, Northwest A&F University, 712100 Yangling, Shaanxi, PR China. Electronic address: .
Pokaż więcej
Źródło :
Research in veterinary science [Res Vet Sci] 2021 Sep; Vol. 138, pp. 69-78. Date of Electronic Publication: 2021 Jun 06.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Animal Husbandry*
Immunologic Factors*/chemical synthesis
Immunologic Factors*/pharmacokinetics
Immunologic Factors*/therapeutic use
Livestock*
Animals ; Biological Availability ; Xanthophylls/chemical synthesis ; Xanthophylls/pharmacokinetics ; Xanthophylls/therapeutic use
Czasopismo naukowe
Tytuł :
The liposome of trehalose dimycolate extracted from M. bovis BCG induces antitumor immunity via the activation of dendritic cells and CD8 T cells.
Autorzy :
Shiga M; Department of Urology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
Miyazaki J; Department of Urology, School of Medicine, International University of Health and Welfare, 852 Hatakeda, Narita, Chiba, 286-0124, Japan. .
Tanuma K; Department of Urology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
Nagumo Y; Department of Urology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
Yoshino T; Department of Urology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
Kandori S; Department of Urology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
Negoro H; Department of Urology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
Kojima T; Department of Urology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
Tanaka R; Department of Dermatology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
Okiyama N; Department of Dermatology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
Fujisawa Y; Department of Dermatology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
Watanabe M; Department of Molecular Immunology, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan.
Yamasaki S; Department of Molecular Immunology, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan.; Laboratory of Molecular Immunology, Immunology Frontier Research Center (WPI-IFReC), Osaka University, Suita, Osaka, Japan.; Division of Molecular Design, Medical Institute of Bioregulation, Kyushu University, Higashi-ku, Fukuoka, Japan.; Division of Molecular Immunology, Medical Mycology Research Center, Chiba University, Chuo-ku, Chiba, Japan.
Kiyohara H; Japan BCG Laboratory, Kiyose, Tokyo, Japan.
Watanabe M; Life Science Research Center, Technology Research Laboratory, Shimadzu, Kyoto, Japan.
Sato TA; Life Science Research Center, Technology Research Laboratory, Shimadzu, Kyoto, Japan.
Tahara H; Project Division of Cancer Biomolecular Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Department of Cancer Drug Discovery and Development, Osaka International Cancer Center, Osaka, Japan.
Nishiyama H; Department of Urology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
Yano I; Osaka City University, Osaka, Japan.
Pokaż więcej
Źródło :
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2021 Sep; Vol. 70 (9), pp. 2529-2543. Date of Electronic Publication: 2021 Feb 11.
Typ publikacji :
Journal Article
MeSH Terms :
Mycobacterium bovis*/chemistry
Antineoplastic Agents, Immunological/*administration & dosage
CD8-Positive T-Lymphocytes/*drug effects
CD8-Positive T-Lymphocytes/*immunology
Cord Factors/*administration & dosage
Dendritic Cells/*drug effects
Dendritic Cells/*immunology
Immunologic Factors/*administration & dosage
Adjuvants, Immunologic ; Animals ; Antineoplastic Agents, Immunological/chemistry ; Antineoplastic Agents, Immunological/isolation & purification ; CD8-Positive T-Lymphocytes/metabolism ; Chemical Fractionation ; Cord Factors/chemistry ; Cord Factors/isolation & purification ; Cytokines/metabolism ; Dendritic Cells/metabolism ; Disease Models, Animal ; Female ; Humans ; Immunologic Factors/chemistry ; Immunologic Factors/isolation & purification ; Immunophenotyping ; Infusions, Parenteral ; Liposomes ; Lymphocyte Activation ; Mice ; Molecular Structure ; Solvents ; Treatment Outcome ; Xenograft Model Antitumor Assays
Czasopismo naukowe
Tytuł :
Anticoronavirus and Immunomodulatory Phenolic Compounds: Opportunities and Pharmacotherapeutic Perspectives.
Autorzy :
Dejani NN; Department of Physiology and Pathology, Federal University of Paraíba, João Pessoa 58051-900, Brazil.
Elshabrawy HA; Department of Molecular and Cellular Biology, College of Osteopathic Medicine, Sam Houston State University, Conroe, TX 77304, USA.
Bezerra Filho CDSM; Department of Pharmaceutical Sciences, Federal University of Paraíba, João Pessoa 58051-900, Brazil.; Postgraduate Program in Bioactive Natural and Synthetic Products, Federal University of Paraíba, João Pessoa 58051-900, Brazil.
de Sousa DP; Department of Pharmaceutical Sciences, Federal University of Paraíba, João Pessoa 58051-900, Brazil.; Postgraduate Program in Bioactive Natural and Synthetic Products, Federal University of Paraíba, João Pessoa 58051-900, Brazil.
Pokaż więcej
Źródło :
Biomolecules [Biomolecules] 2021 Aug 23; Vol. 11 (8). Date of Electronic Publication: 2021 Aug 23.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Antiviral Agents/*therapeutic use
COVID-19/*drug therapy
Flavonoids/*therapeutic use
Immunologic Factors/*therapeutic use
Phytochemicals/*therapeutic use
Protease Inhibitors/*therapeutic use
Animals ; Antiviral Agents/chemistry ; Antiviral Agents/pharmacology ; Coronavirus/drug effects ; Flavonoids/chemistry ; Flavonoids/pharmacology ; Humans ; Immunologic Factors/chemistry ; Immunologic Factors/pharmacology ; Phytochemicals/chemistry ; Phytochemicals/pharmacology ; Protease Inhibitors/chemistry ; Protease Inhibitors/pharmacology
Czasopismo naukowe
Tytuł :
A qualitative and quantitative comparison of Crocus sativus and Nigella sativa immunomodulatory effects.
Autorzy :
Khazdair MR; Cardiovascular Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran.
Gholamnezhad Z; Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; Department of Physiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Rezaee R; Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; Clinical Research Development Unit, Imam Reza Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Boskabady MH; Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; Department of Physiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Electronic address: .
Pokaż więcej
Źródło :
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2021 Aug; Vol. 140, pp. 111774. Date of Electronic Publication: 2021 May 29.
Typ publikacji :
Comparative Study; Journal Article; Review
MeSH Terms :
Crocus*/chemistry
Nigella sativa*/chemistry
Immune System Diseases/*drug therapy
Immunologic Factors/*therapeutic use
Plant Extracts/*therapeutic use
Animals ; Humans ; Immune System Diseases/immunology ; Immunologic Factors/chemistry ; Immunologic Factors/pharmacology ; Phytochemicals/analysis ; Phytochemicals/pharmacology ; Phytochemicals/therapeutic use ; Plant Extracts/chemistry ; Plant Extracts/pharmacology
Czasopismo naukowe
Tytuł :
Humoral immune response in convalescent COVID-19 people with multiple sclerosis treated with high-efficacy disease-modifying therapies: A multicenter, case-control study.
Autorzy :
Habek M; Department of Neurology, University Hospital Center Zagreb, Zagreb, Croatia; School of Medicine, University of Zagreb, Zagreb, Croatia. Electronic address: .
Jakob Brecl G; Department of Neurology, University Medical Centre Ljubljana, Ljubljana, Slovenia.
Bašić Kes V; Department of Neurology, University Hospital Center 'Sestre Milosrdnice', Zagreb, Croatia.
Rogić D; Clinical Institute for Laboratory Diagnostics, University Hospital Center Zagreb, Zagreb, Croatia. Electronic address: .
Barun B; Department of Neurology, University Hospital Center Zagreb, Zagreb, Croatia; School of Medicine, University of Zagreb, Zagreb, Croatia.
Gabelić T; Department of Neurology, University Hospital Center Zagreb, Zagreb, Croatia; School of Medicine, University of Zagreb, Zagreb, Croatia.
Emeršič A; Department of Neurology, University Medical Centre Ljubljana, Ljubljana, Slovenia. Electronic address: .
Horvat Ledinek A; Department of Neurology, University Medical Centre Ljubljana, Ljubljana, Slovenia. Electronic address: .
Grbić N; Department of Neurology, University Hospital Center 'Sestre Milosrdnice', Zagreb, Croatia.
Lapić I; Clinical Institute for Laboratory Diagnostics, University Hospital Center Zagreb, Zagreb, Croatia. Electronic address: .
Šegulja D; Clinical Institute for Laboratory Diagnostics, University Hospital Center Zagreb, Zagreb, Croatia. Electronic address: .
Đurić K; Department for Laboratory Diagnostics, Special Hospital AGRAM, Zagreb, Croatia. Electronic address: .
Adamec I; Department of Neurology, University Hospital Center Zagreb, Zagreb, Croatia.
Krbot Skorić M; Department of Neurology, University Hospital Center Zagreb, Zagreb, Croatia; Faculty of Electrical Engineering and Computing, University of Zagreb, Zagreb, Croatia.
Pokaż więcej
Źródło :
Journal of neuroimmunology [J Neuroimmunol] 2021 Oct 15; Vol. 359, pp. 577696. Date of Electronic Publication: 2021 Aug 16.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
COVID-19/*drug therapy
COVID-19/*immunology
Immunity, Humoral/*immunology
Immunologic Factors/*therapeutic use
Immunosuppressive Agents/*therapeutic use
SARS-CoV-2/*immunology
Adult ; Antibodies, Viral/blood ; Antibodies, Viral/immunology ; COVID-19/blood ; Case-Control Studies ; Female ; Humans ; Immunity, Humoral/drug effects ; Immunologic Factors/pharmacology ; Immunosuppressive Agents/pharmacology ; Male ; Middle Aged ; SARS-CoV-2/metabolism ; Treatment Outcome
Czasopismo naukowe
Tytuł :
A systematic review on efficacy, safety, and treatment-durability of low-dose rituximab for the treatment of Pemphigus: special focus on COVID-19 pandemic concerns.
Autorzy :
Tavakolpour S; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Aryanian Z; Autoimmune Bullous Diseases Research Center, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran.; Department of Dermatology, Babol University of Medical Sciences, Babol, Iran.
Seirafianpour F; Student Research Committee, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Dodangeh M; Student Research Committee, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Etesami I; Autoimmune Bullous Diseases Research Center, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Daneshpazhooh M; Autoimmune Bullous Diseases Research Center, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Balighi K; Autoimmune Bullous Diseases Research Center, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Mahmoudi H; Autoimmune Bullous Diseases Research Center, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Goodarzi A; Department of Dermatology, Rasool Akram Medical Complex, Iran University of Medical Sciences, Tehran, Iran.
Pokaż więcej
Źródło :
Immunopharmacology and immunotoxicology [Immunopharmacol Immunotoxicol] 2021 Oct; Vol. 43 (5), pp. 507-518. Date of Electronic Publication: 2021 Jul 21.
Typ publikacji :
Journal Article; Systematic Review
MeSH Terms :
Immunocompromised Host*
COVID-19/*immunology
Immunologic Factors/*administration & dosage
Pemphigus/*drug therapy
Rituximab/*administration & dosage
Adolescent ; Adult ; Aged ; Aged, 80 and over ; COVID-19/diagnosis ; COVID-19/virology ; Child ; Female ; Humans ; Immunologic Factors/adverse effects ; Male ; Middle Aged ; Pemphigus/diagnosis ; Pemphigus/immunology ; Remission Induction ; Risk Factors ; Rituximab/adverse effects ; SARS-CoV-2/immunology ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł :
Anti-inflammatory Therapy by Cholinergic and Purinergic Modulation in Multiple Sclerosis Associated with SARS-CoV-2 Infection.
Autorzy :
Simões JLB; Medical School, Federal University of Fronteira Sul, Chapecó, SC, Brazil.
de Araújo JB; Medical School, Federal University of Fronteira Sul, Chapecó, SC, Brazil.
Bagatini MD; Graduate Program in Medical Sciences, Federal University of Fronteira Sul, Chapecó, SC, Brazil. .
Pokaż więcej
Źródło :
Molecular neurobiology [Mol Neurobiol] 2021 Oct; Vol. 58 (10), pp. 5090-5111. Date of Electronic Publication: 2021 Jul 11.
Typ publikacji :
Journal Article; Review
MeSH Terms :
COVID-19/*metabolism
Cytokine Release Syndrome/*metabolism
Immunologic Factors/*therapeutic use
Multiple Sclerosis/*metabolism
Cytokine Release Syndrome/etiology ; Cytokines/metabolism ; Humans ; Immunologic Factors/adverse effects ; Microglia/metabolism ; Multiple Sclerosis/drug therapy
Czasopismo naukowe
Tytuł :
A New England COVID-19 Registry of Patients With CNS Demyelinating Disease: A Pilot Analysis.
Autorzy :
Money KM; From the Department of Neurology (K.M.M., A.M., S.S., U.B., J.A.S.), Beth Israel Deaconess Medical Center, Boston; Department of Neurology (P.A.), Boston University School of Medicine, MA; The Mandell Comprehensive MS Center (M.B., P.W.), Hartford, CT; Department of Neurology (R.B., M.H.), Brigham and Women's Hospital, Boston; The Elliot Lewis Center (A. Bouley, J.K., E. Lathi), Wellesley, MA; Department of Neurology (A. Bower, E. Levit, E.E.L.), Yale School of Medicine, New Haven, CT; Department of Neurology (J.C.), Alpert Medical School of Brown University, Providence, RI; Department of Neurology (M.M.), Lahey Hospital, Burlington; Neurology Center of New England (S.N.), Foxboro, MA; and Department of Neurology (P.R.), Concord Hospital, Concord, NH.
Mahatoo A; From the Department of Neurology (K.M.M., A.M., S.S., U.B., J.A.S.), Beth Israel Deaconess Medical Center, Boston; Department of Neurology (P.A.), Boston University School of Medicine, MA; The Mandell Comprehensive MS Center (M.B., P.W.), Hartford, CT; Department of Neurology (R.B., M.H.), Brigham and Women's Hospital, Boston; The Elliot Lewis Center (A. Bouley, J.K., E. Lathi), Wellesley, MA; Department of Neurology (A. Bower, E. Levit, E.E.L.), Yale School of Medicine, New Haven, CT; Department of Neurology (J.C.), Alpert Medical School of Brown University, Providence, RI; Department of Neurology (M.M.), Lahey Hospital, Burlington; Neurology Center of New England (S.N.), Foxboro, MA; and Department of Neurology (P.R.), Concord Hospital, Concord, NH.
Samaan S; From the Department of Neurology (K.M.M., A.M., S.S., U.B., J.A.S.), Beth Israel Deaconess Medical Center, Boston; Department of Neurology (P.A.), Boston University School of Medicine, MA; The Mandell Comprehensive MS Center (M.B., P.W.), Hartford, CT; Department of Neurology (R.B., M.H.), Brigham and Women's Hospital, Boston; The Elliot Lewis Center (A. Bouley, J.K., E. Lathi), Wellesley, MA; Department of Neurology (A. Bower, E. Levit, E.E.L.), Yale School of Medicine, New Haven, CT; Department of Neurology (J.C.), Alpert Medical School of Brown University, Providence, RI; Department of Neurology (M.M.), Lahey Hospital, Burlington; Neurology Center of New England (S.N.), Foxboro, MA; and Department of Neurology (P.R.), Concord Hospital, Concord, NH.
Anand P; From the Department of Neurology (K.M.M., A.M., S.S., U.B., J.A.S.), Beth Israel Deaconess Medical Center, Boston; Department of Neurology (P.A.), Boston University School of Medicine, MA; The Mandell Comprehensive MS Center (M.B., P.W.), Hartford, CT; Department of Neurology (R.B., M.H.), Brigham and Women's Hospital, Boston; The Elliot Lewis Center (A. Bouley, J.K., E. Lathi), Wellesley, MA; Department of Neurology (A. Bower, E. Levit, E.E.L.), Yale School of Medicine, New Haven, CT; Department of Neurology (J.C.), Alpert Medical School of Brown University, Providence, RI; Department of Neurology (M.M.), Lahey Hospital, Burlington; Neurology Center of New England (S.N.), Foxboro, MA; and Department of Neurology (P.R.), Concord Hospital, Concord, NH.
Baber U; From the Department of Neurology (K.M.M., A.M., S.S., U.B., J.A.S.), Beth Israel Deaconess Medical Center, Boston; Department of Neurology (P.A.), Boston University School of Medicine, MA; The Mandell Comprehensive MS Center (M.B., P.W.), Hartford, CT; Department of Neurology (R.B., M.H.), Brigham and Women's Hospital, Boston; The Elliot Lewis Center (A. Bouley, J.K., E. Lathi), Wellesley, MA; Department of Neurology (A. Bower, E. Levit, E.E.L.), Yale School of Medicine, New Haven, CT; Department of Neurology (J.C.), Alpert Medical School of Brown University, Providence, RI; Department of Neurology (M.M.), Lahey Hospital, Burlington; Neurology Center of New England (S.N.), Foxboro, MA; and Department of Neurology (P.R.), Concord Hospital, Concord, NH.
Bailey M; From the Department of Neurology (K.M.M., A.M., S.S., U.B., J.A.S.), Beth Israel Deaconess Medical Center, Boston; Department of Neurology (P.A.), Boston University School of Medicine, MA; The Mandell Comprehensive MS Center (M.B., P.W.), Hartford, CT; Department of Neurology (R.B., M.H.), Brigham and Women's Hospital, Boston; The Elliot Lewis Center (A. Bouley, J.K., E. Lathi), Wellesley, MA; Department of Neurology (A. Bower, E. Levit, E.E.L.), Yale School of Medicine, New Haven, CT; Department of Neurology (J.C.), Alpert Medical School of Brown University, Providence, RI; Department of Neurology (M.M.), Lahey Hospital, Burlington; Neurology Center of New England (S.N.), Foxboro, MA; and Department of Neurology (P.R.), Concord Hospital, Concord, NH.
Bakshi R; From the Department of Neurology (K.M.M., A.M., S.S., U.B., J.A.S.), Beth Israel Deaconess Medical Center, Boston; Department of Neurology (P.A.), Boston University School of Medicine, MA; The Mandell Comprehensive MS Center (M.B., P.W.), Hartford, CT; Department of Neurology (R.B., M.H.), Brigham and Women's Hospital, Boston; The Elliot Lewis Center (A. Bouley, J.K., E. Lathi), Wellesley, MA; Department of Neurology (A. Bower, E. Levit, E.E.L.), Yale School of Medicine, New Haven, CT; Department of Neurology (J.C.), Alpert Medical School of Brown University, Providence, RI; Department of Neurology (M.M.), Lahey Hospital, Burlington; Neurology Center of New England (S.N.), Foxboro, MA; and Department of Neurology (P.R.), Concord Hospital, Concord, NH.
Bouley A; From the Department of Neurology (K.M.M., A.M., S.S., U.B., J.A.S.), Beth Israel Deaconess Medical Center, Boston; Department of Neurology (P.A.), Boston University School of Medicine, MA; The Mandell Comprehensive MS Center (M.B., P.W.), Hartford, CT; Department of Neurology (R.B., M.H.), Brigham and Women's Hospital, Boston; The Elliot Lewis Center (A. Bouley, J.K., E. Lathi), Wellesley, MA; Department of Neurology (A. Bower, E. Levit, E.E.L.), Yale School of Medicine, New Haven, CT; Department of Neurology (J.C.), Alpert Medical School of Brown University, Providence, RI; Department of Neurology (M.M.), Lahey Hospital, Burlington; Neurology Center of New England (S.N.), Foxboro, MA; and Department of Neurology (P.R.), Concord Hospital, Concord, NH.
Bower A; From the Department of Neurology (K.M.M., A.M., S.S., U.B., J.A.S.), Beth Israel Deaconess Medical Center, Boston; Department of Neurology (P.A.), Boston University School of Medicine, MA; The Mandell Comprehensive MS Center (M.B., P.W.), Hartford, CT; Department of Neurology (R.B., M.H.), Brigham and Women's Hospital, Boston; The Elliot Lewis Center (A. Bouley, J.K., E. Lathi), Wellesley, MA; Department of Neurology (A. Bower, E. Levit, E.E.L.), Yale School of Medicine, New Haven, CT; Department of Neurology (J.C.), Alpert Medical School of Brown University, Providence, RI; Department of Neurology (M.M.), Lahey Hospital, Burlington; Neurology Center of New England (S.N.), Foxboro, MA; and Department of Neurology (P.R.), Concord Hospital, Concord, NH.
Cahill J; From the Department of Neurology (K.M.M., A.M., S.S., U.B., J.A.S.), Beth Israel Deaconess Medical Center, Boston; Department of Neurology (P.A.), Boston University School of Medicine, MA; The Mandell Comprehensive MS Center (M.B., P.W.), Hartford, CT; Department of Neurology (R.B., M.H.), Brigham and Women's Hospital, Boston; The Elliot Lewis Center (A. Bouley, J.K., E. Lathi), Wellesley, MA; Department of Neurology (A. Bower, E. Levit, E.E.L.), Yale School of Medicine, New Haven, CT; Department of Neurology (J.C.), Alpert Medical School of Brown University, Providence, RI; Department of Neurology (M.M.), Lahey Hospital, Burlington; Neurology Center of New England (S.N.), Foxboro, MA; and Department of Neurology (P.R.), Concord Hospital, Concord, NH.
Houtchens M; From the Department of Neurology (K.M.M., A.M., S.S., U.B., J.A.S.), Beth Israel Deaconess Medical Center, Boston; Department of Neurology (P.A.), Boston University School of Medicine, MA; The Mandell Comprehensive MS Center (M.B., P.W.), Hartford, CT; Department of Neurology (R.B., M.H.), Brigham and Women's Hospital, Boston; The Elliot Lewis Center (A. Bouley, J.K., E. Lathi), Wellesley, MA; Department of Neurology (A. Bower, E. Levit, E.E.L.), Yale School of Medicine, New Haven, CT; Department of Neurology (J.C.), Alpert Medical School of Brown University, Providence, RI; Department of Neurology (M.M.), Lahey Hospital, Burlington; Neurology Center of New England (S.N.), Foxboro, MA; and Department of Neurology (P.R.), Concord Hospital, Concord, NH.
Katz J; From the Department of Neurology (K.M.M., A.M., S.S., U.B., J.A.S.), Beth Israel Deaconess Medical Center, Boston; Department of Neurology (P.A.), Boston University School of Medicine, MA; The Mandell Comprehensive MS Center (M.B., P.W.), Hartford, CT; Department of Neurology (R.B., M.H.), Brigham and Women's Hospital, Boston; The Elliot Lewis Center (A. Bouley, J.K., E. Lathi), Wellesley, MA; Department of Neurology (A. Bower, E. Levit, E.E.L.), Yale School of Medicine, New Haven, CT; Department of Neurology (J.C.), Alpert Medical School of Brown University, Providence, RI; Department of Neurology (M.M.), Lahey Hospital, Burlington; Neurology Center of New England (S.N.), Foxboro, MA; and Department of Neurology (P.R.), Concord Hospital, Concord, NH.
Lathi E; From the Department of Neurology (K.M.M., A.M., S.S., U.B., J.A.S.), Beth Israel Deaconess Medical Center, Boston; Department of Neurology (P.A.), Boston University School of Medicine, MA; The Mandell Comprehensive MS Center (M.B., P.W.), Hartford, CT; Department of Neurology (R.B., M.H.), Brigham and Women's Hospital, Boston; The Elliot Lewis Center (A. Bouley, J.K., E. Lathi), Wellesley, MA; Department of Neurology (A. Bower, E. Levit, E.E.L.), Yale School of Medicine, New Haven, CT; Department of Neurology (J.C.), Alpert Medical School of Brown University, Providence, RI; Department of Neurology (M.M.), Lahey Hospital, Burlington; Neurology Center of New England (S.N.), Foxboro, MA; and Department of Neurology (P.R.), Concord Hospital, Concord, NH.
Levit E; From the Department of Neurology (K.M.M., A.M., S.S., U.B., J.A.S.), Beth Israel Deaconess Medical Center, Boston; Department of Neurology (P.A.), Boston University School of Medicine, MA; The Mandell Comprehensive MS Center (M.B., P.W.), Hartford, CT; Department of Neurology (R.B., M.H.), Brigham and Women's Hospital, Boston; The Elliot Lewis Center (A. Bouley, J.K., E. Lathi), Wellesley, MA; Department of Neurology (A. Bower, E. Levit, E.E.L.), Yale School of Medicine, New Haven, CT; Department of Neurology (J.C.), Alpert Medical School of Brown University, Providence, RI; Department of Neurology (M.M.), Lahey Hospital, Burlington; Neurology Center of New England (S.N.), Foxboro, MA; and Department of Neurology (P.R.), Concord Hospital, Concord, NH.
Longbrake EE; From the Department of Neurology (K.M.M., A.M., S.S., U.B., J.A.S.), Beth Israel Deaconess Medical Center, Boston; Department of Neurology (P.A.), Boston University School of Medicine, MA; The Mandell Comprehensive MS Center (M.B., P.W.), Hartford, CT; Department of Neurology (R.B., M.H.), Brigham and Women's Hospital, Boston; The Elliot Lewis Center (A. Bouley, J.K., E. Lathi), Wellesley, MA; Department of Neurology (A. Bower, E. Levit, E.E.L.), Yale School of Medicine, New Haven, CT; Department of Neurology (J.C.), Alpert Medical School of Brown University, Providence, RI; Department of Neurology (M.M.), Lahey Hospital, Burlington; Neurology Center of New England (S.N.), Foxboro, MA; and Department of Neurology (P.R.), Concord Hospital, Concord, NH.
McAdams M; From the Department of Neurology (K.M.M., A.M., S.S., U.B., J.A.S.), Beth Israel Deaconess Medical Center, Boston; Department of Neurology (P.A.), Boston University School of Medicine, MA; The Mandell Comprehensive MS Center (M.B., P.W.), Hartford, CT; Department of Neurology (R.B., M.H.), Brigham and Women's Hospital, Boston; The Elliot Lewis Center (A. Bouley, J.K., E. Lathi), Wellesley, MA; Department of Neurology (A. Bower, E. Levit, E.E.L.), Yale School of Medicine, New Haven, CT; Department of Neurology (J.C.), Alpert Medical School of Brown University, Providence, RI; Department of Neurology (M.M.), Lahey Hospital, Burlington; Neurology Center of New England (S.N.), Foxboro, MA; and Department of Neurology (P.R.), Concord Hospital, Concord, NH.
Napoli S; From the Department of Neurology (K.M.M., A.M., S.S., U.B., J.A.S.), Beth Israel Deaconess Medical Center, Boston; Department of Neurology (P.A.), Boston University School of Medicine, MA; The Mandell Comprehensive MS Center (M.B., P.W.), Hartford, CT; Department of Neurology (R.B., M.H.), Brigham and Women's Hospital, Boston; The Elliot Lewis Center (A. Bouley, J.K., E. Lathi), Wellesley, MA; Department of Neurology (A. Bower, E. Levit, E.E.L.), Yale School of Medicine, New Haven, CT; Department of Neurology (J.C.), Alpert Medical School of Brown University, Providence, RI; Department of Neurology (M.M.), Lahey Hospital, Burlington; Neurology Center of New England (S.N.), Foxboro, MA; and Department of Neurology (P.R.), Concord Hospital, Concord, NH.
Raibagkar P; From the Department of Neurology (K.M.M., A.M., S.S., U.B., J.A.S.), Beth Israel Deaconess Medical Center, Boston; Department of Neurology (P.A.), Boston University School of Medicine, MA; The Mandell Comprehensive MS Center (M.B., P.W.), Hartford, CT; Department of Neurology (R.B., M.H.), Brigham and Women's Hospital, Boston; The Elliot Lewis Center (A. Bouley, J.K., E. Lathi), Wellesley, MA; Department of Neurology (A. Bower, E. Levit, E.E.L.), Yale School of Medicine, New Haven, CT; Department of Neurology (J.C.), Alpert Medical School of Brown University, Providence, RI; Department of Neurology (M.M.), Lahey Hospital, Burlington; Neurology Center of New England (S.N.), Foxboro, MA; and Department of Neurology (P.R.), Concord Hospital, Concord, NH.
Wade P; From the Department of Neurology (K.M.M., A.M., S.S., U.B., J.A.S.), Beth Israel Deaconess Medical Center, Boston; Department of Neurology (P.A.), Boston University School of Medicine, MA; The Mandell Comprehensive MS Center (M.B., P.W.), Hartford, CT; Department of Neurology (R.B., M.H.), Brigham and Women's Hospital, Boston; The Elliot Lewis Center (A. Bouley, J.K., E. Lathi), Wellesley, MA; Department of Neurology (A. Bower, E. Levit, E.E.L.), Yale School of Medicine, New Haven, CT; Department of Neurology (J.C.), Alpert Medical School of Brown University, Providence, RI; Department of Neurology (M.M.), Lahey Hospital, Burlington; Neurology Center of New England (S.N.), Foxboro, MA; and Department of Neurology (P.R.), Concord Hospital, Concord, NH.
Sloane JA; From the Department of Neurology (K.M.M., A.M., S.S., U.B., J.A.S.), Beth Israel Deaconess Medical Center, Boston; Department of Neurology (P.A.), Boston University School of Medicine, MA; The Mandell Comprehensive MS Center (M.B., P.W.), Hartford, CT; Department of Neurology (R.B., M.H.), Brigham and Women's Hospital, Boston; The Elliot Lewis Center (A. Bouley, J.K., E. Lathi), Wellesley, MA; Department of Neurology (A. Bower, E. Levit, E.E.L.), Yale School of Medicine, New Haven, CT; Department of Neurology (J.C.), Alpert Medical School of Brown University, Providence, RI; Department of Neurology (M.M.), Lahey Hospital, Burlington; Neurology Center of New England (S.N.), Foxboro, MA; and Department of Neurology (P.R.), Concord Hospital, Concord, NH. .
Pokaż więcej
Źródło :
Neurology(R) neuroimmunology & neuroinflammation [Neurol Neuroimmunol Neuroinflamm] 2021 Aug 02; Vol. 8 (5). Date of Electronic Publication: 2021 Aug 02 (Print Publication: 2021).
Typ publikacji :
Journal Article
MeSH Terms :
COVID-19*/diagnosis
COVID-19*/epidemiology
COVID-19*/therapy
Demyelinating Autoimmune Diseases, CNS*/drug therapy
Demyelinating Autoimmune Diseases, CNS*/epidemiology
Hospitalization/*statistics & numerical data
Immunologic Factors/*therapeutic use
Registries/*statistics & numerical data
Respiration, Artificial/*statistics & numerical data
Adult ; Cohort Studies ; Comorbidity ; Female ; Humans ; Immunologic Factors/adverse effects ; Male ; Middle Aged ; Mortality ; New England/epidemiology ; Pilot Projects ; Risk Factors ; Severity of Illness Index
Czasopismo naukowe
Tytuł :
Risk of invasive fungal infections among patients treated with disease modifying treatments for multiple sclerosis: a comprehensive review.
Autorzy :
Scotto R; Department of Clinical Medicine and Surgery, Section of Infectious Diseases, University of Naples Federico II, Naples, Italy.
Reia A; Department of Neuroscience, Reproductive Science and Odontostomatology, Multiple Sclerosis Clinical Care and Research Centre, University of Naples Federico II, Italy.
Buonomo AR; Department of Clinical Medicine and Surgery, Section of Infectious Diseases, University of Naples Federico II, Naples, Italy.
Moccia M; Department of Neuroscience, Reproductive Science and Odontostomatology, Multiple Sclerosis Clinical Care and Research Centre, University of Naples Federico II, Italy.
Viceconte G; Department of Clinical Medicine and Surgery, Section of Infectious Diseases, University of Naples Federico II, Naples, Italy.
Pisano E; Department of Neuroscience, Reproductive Science and Odontostomatology, Multiple Sclerosis Clinical Care and Research Centre, University of Naples Federico II, Italy.
Zappulo E; Department of Clinical Medicine and Surgery, Section of Infectious Diseases, University of Naples Federico II, Naples, Italy.
Brescia Morra V; Department of Neuroscience, Reproductive Science and Odontostomatology, Multiple Sclerosis Clinical Care and Research Centre, University of Naples Federico II, Italy.
Gentile I; Department of Clinical Medicine and Surgery, Section of Infectious Diseases, University of Naples Federico II, Naples, Italy.
Pokaż więcej
Źródło :
Expert opinion on drug safety [Expert Opin Drug Saf] 2021 Aug; Vol. 20 (8), pp. 925-936. Date of Electronic Publication: 2021 Apr 21.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Immunologic Factors/*adverse effects
Invasive Fungal Infections/*etiology
Multiple Sclerosis/*drug therapy
Humans ; Immunologic Factors/administration & dosage ; Immunosuppressive Agents/administration & dosage ; Immunosuppressive Agents/adverse effects ; Invasive Fungal Infections/diagnosis ; Invasive Fungal Infections/microbiology ; Opportunistic Infections/diagnosis ; Opportunistic Infections/microbiology ; Risk
Czasopismo naukowe
Tytuł :
Comparative safety of systemic immunomodulatory medications in adults with atopic dermatitis.
Autorzy :
Schneeweiss MC; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; Department of Medicine, Division of Pharamacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Perez-Chada L; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Merola JF; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: .
Pokaż więcej
Źródło :
Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2021 Aug; Vol. 85 (2), pp. 321-329. Date of Electronic Publication: 2019 May 31.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Bacterial Infections/*etiology
Dermatitis, Atopic/*drug therapy
Immunologic Factors/*therapeutic use
Opportunistic Infections/*etiology
Adult ; Aged ; Bacterial Infections/epidemiology ; Cohort Studies ; Female ; Humans ; Immunologic Factors/adverse effects ; Incidence ; Male ; Middle Aged ; Opportunistic Infections/epidemiology ; Risk Assessment ; Severity of Illness Index
Czasopismo naukowe
Tytuł :
Amelioration of immune and digestive system through weed supplemented feed against Aeromonas hydrophila in Clarias gariepinus.
Autorzy :
Verma VK; Department of Zoology, Sri Venkateswara College, University of Delhi, New Delhi, 110021, India.
Kumar KB; Department of Zoology, Sri Venkateswara College, University of Delhi, New Delhi, 110021, India.
Sagar K; Department of Zoology, Sri Venkateswara College, University of Delhi, New Delhi, 110021, India.
Majumdar S; Department of Zoology, Sri Venkateswara College, University of Delhi, New Delhi, 110021, India.
Pal S; Department of Zoology, Sri Venkateswara College, University of Delhi, New Delhi, 110021, India.
Mehta A; Department of Zoology, Sri Venkateswara College, University of Delhi, New Delhi, 110021, India.
Vats A; Department of Zoology, Sri Venkateswara College, University of Delhi, New Delhi, 110021, India.
Rani KV; Department of Zoology, Kalindi College, University of Delhi, New Delhi, 110008, India.
Sehgal N; Department of Zoology, University of Delhi, New Delhi, 110007, India.
Prakash O; Department of Zoology, Sri Venkateswara College, University of Delhi, New Delhi, 110021, India. Electronic address: .
Pokaż więcej
Źródło :
Fish & shellfish immunology [Fish Shellfish Immunol] 2021 Aug; Vol. 115, pp. 124-133. Date of Electronic Publication: 2021 May 30.
Typ publikacji :
Journal Article
MeSH Terms :
Adaptive Immunity/*drug effects
Catfishes/*physiology
Digestive System/*drug effects
Ferns/*chemistry
Immunity, Innate/*drug effects
Immunologic Factors/*metabolism
Magnoliopsida/*chemistry
Animal Feed/analysis ; Animals ; Catfishes/immunology ; Diet/veterinary ; Dietary Supplements/analysis ; Dose-Response Relationship, Drug ; Immunologic Factors/administration & dosage ; Male ; Polypodiaceae
Czasopismo naukowe
Tytuł :
Granulocyte-macrophage colony-stimulating factor: an immunotarget for sepsis and COVID-19.
Autorzy :
Mu X; Peking University 302 Clinical Medical School, Beijing, China.
Liu K; Peking University 302 Clinical Medical School, Beijing, China.; Department of Infectious Diseases, Fifth Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing, China.
Li H; Peking University 302 Clinical Medical School, Beijing, China.
Wang FS; Peking University 302 Clinical Medical School, Beijing, China. .; Department of Infectious Diseases, Fifth Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing, China. .
Xu R; Department of Infectious Diseases, Fifth Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing, China. .
Pokaż więcej
Źródło :
Cellular & molecular immunology [Cell Mol Immunol] 2021 Aug; Vol. 18 (8), pp. 2057-2058. Date of Electronic Publication: 2021 Jul 19.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
COVID-19/*drug therapy
Granulocyte-Macrophage Colony-Stimulating Factor/*therapeutic use
Immunologic Factors/*therapeutic use
SARS-CoV-2/*pathogenicity
Sepsis/*drug therapy
Animals ; COVID-19/immunology ; COVID-19/virology ; Granulocyte-Macrophage Colony-Stimulating Factor/adverse effects ; Granulocyte-Macrophage Colony-Stimulating Factor/antagonists & inhibitors ; Granulocyte-Macrophage Colony-Stimulating Factor/metabolism ; Host-Pathogen Interactions ; Humans ; Immunologic Factors/adverse effects ; Recombinant Proteins/therapeutic use ; SARS-CoV-2/immunology ; Sepsis/immunology ; Sepsis/virology ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Nanobodies as powerful pulmonary targeted biotherapeutics against SARS-CoV-2, pharmaceutical point of view.
Autorzy :
Najmeddin A; Department of Pharmaceutics, Faculty of pharmacy, Tehran University of Medical Sciences, Iran. Electronic address: .
Bahrololoumi Shapourabadi M; HUM Immune Biotechnology Institute, Tehran, Iran. Electronic address: .
Behdani M; Venom and Biotherapeutic Molecules Lab, Biotechnology Research Centre, Pasteur Institute of Iran, Tehran, Iran. Electronic address: .
Dorkoosh F; Department of Pharmaceutics, Faculty of pharmacy, Tehran University of Medical Sciences, Iran; Medical Biomaterial Research Center (MBRC), Tehran University of Medical Sciences, Iran. Electronic address: .
Pokaż więcej
Źródło :
Biochimica et biophysica acta. General subjects [Biochim Biophys Acta Gen Subj] 2021 Nov; Vol. 1865 (11), pp. 129974. Date of Electronic Publication: 2021 Jul 31.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Antibodies, Neutralizing/*therapeutic use
Antiviral Agents/*therapeutic use
COVID-19/*therapy
Immunologic Factors/*therapeutic use
SARS-CoV-2/*drug effects
Single-Domain Antibodies/*therapeutic use
Spike Glycoprotein, Coronavirus/*antagonists & inhibitors
Angiotensin-Converting Enzyme 2/antagonists & inhibitors ; Angiotensin-Converting Enzyme 2/genetics ; Angiotensin-Converting Enzyme 2/immunology ; Animals ; Antibodies, Neutralizing/biosynthesis ; Antibodies, Neutralizing/isolation & purification ; Antiviral Agents/isolation & purification ; Antiviral Agents/metabolism ; COVID-19/immunology ; COVID-19/virology ; Camelus ; Drug Delivery Systems ; Humans ; Immune Sera/chemistry ; Immunologic Factors/biosynthesis ; Immunologic Factors/isolation & purification ; Lung/drug effects ; Lung/immunology ; Lung/virology ; Molecular Targeted Therapy/methods ; Peptide Library ; Protein Binding/drug effects ; SARS-CoV-2/genetics ; SARS-CoV-2/immunology ; Single-Domain Antibodies/biosynthesis ; Single-Domain Antibodies/isolation & purification ; Spike Glycoprotein, Coronavirus/genetics ; Spike Glycoprotein, Coronavirus/immunology
Czasopismo naukowe
Tytuł :
Structural characterization and immunomodulatory mechanisms of two novel glucans from Morchella importuna fruiting bodies.
Autorzy :
Wen Y; Biotechnological Institute of Chinese Materia Medica, College of Pharmacy, Jinan University, 601 Huangpu Avenue West, Guangzhou 510632, China; School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Bi S; Department of Pharmacology, Jinan University, 601 Huangpu Avenue West, Guangzhou 510632, China.
Hu X; Department of Natural Products Chemistry, College of Pharmacy, Jinan University, 601 Huangpu Avenue West, Guangzhou 510632, China.
Yang J; Department of Pharmacology, Jinan University, 601 Huangpu Avenue West, Guangzhou 510632, China.
Li C; Biotechnological Institute of Chinese Materia Medica, College of Pharmacy, Jinan University, 601 Huangpu Avenue West, Guangzhou 510632, China.
Li H; Department of Natural Products Chemistry, College of Pharmacy, Jinan University, 601 Huangpu Avenue West, Guangzhou 510632, China.
Yu DB; Department of Cardiovascular Care, ThedaCare Regional Medical Center, Appleton, WI, USA.
Zhu J; Department of Natural Products Chemistry, College of Pharmacy, Jinan University, 601 Huangpu Avenue West, Guangzhou 510632, China. Electronic address: .
Song L; Department of Pharmacology, Jinan University, 601 Huangpu Avenue West, Guangzhou 510632, China. Electronic address: .
Yu R; Biotechnological Institute of Chinese Materia Medica, College of Pharmacy, Jinan University, 601 Huangpu Avenue West, Guangzhou 510632, China; Department of Natural Products Chemistry, College of Pharmacy, Jinan University, 601 Huangpu Avenue West, Guangzhou 510632, China. Electronic address: .
Pokaż więcej
Źródło :
International journal of biological macromolecules [Int J Biol Macromol] 2021 Jul 31; Vol. 183, pp. 145-157. Date of Electronic Publication: 2021 Apr 18.
Typ publikacji :
Journal Article
MeSH Terms :
Ascomycota/*metabolism
Fruiting Bodies, Fungal/*metabolism
Glucans/*pharmacology
Immunologic Factors/*pharmacology
Macrophages/*drug effects
Animals ; Glucans/chemistry ; Glucans/isolation & purification ; Immunologic Factors/chemistry ; Immunologic Factors/isolation & purification ; Interleukin-6/metabolism ; Macrophages/immunology ; Macrophages/metabolism ; Mice ; Mitogen-Activated Protein Kinases/metabolism ; Molecular Structure ; NF-kappa B/metabolism ; Nitric Oxide/metabolism ; Phagocytosis/drug effects ; RAW 264.7 Cells ; Signal Transduction ; Structure-Activity Relationship ; Toll-Like Receptor 2/metabolism ; Toll-Like Receptor 4/metabolism ; Tumor Necrosis Factor-alpha/metabolism
SCR Organism :
Morchella importuna
Czasopismo naukowe
Tytuł :
Classification, structure and mechanism of antiviral polysaccharides derived from edible and medicinal fungus.
Autorzy :
Guo Y; School of Food and Biological Engineering, Shaanxi University of Science and Technology, Xi'an 710021, China.
Chen X; School of Food and Biological Engineering, Shaanxi University of Science and Technology, Xi'an 710021, China; Shaanxi Research Institute of Agricultural Product Processing Technology, Xi'an 710021, China.
Gong P; School of Food and Biological Engineering, Shaanxi University of Science and Technology, Xi'an 710021, China. Electronic address: .
Pokaż więcej
Źródło :
International journal of biological macromolecules [Int J Biol Macromol] 2021 Jul 31; Vol. 183, pp. 1753-1773. Date of Electronic Publication: 2021 May 25.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Anti-Inflammatory Agents*/chemistry
Anti-Inflammatory Agents*/classification
Anti-Inflammatory Agents*/therapeutic use
Antiviral Agents*/chemistry
Antiviral Agents*/classification
Antiviral Agents*/therapeutic use
Fungal Polysaccharides*/chemistry
Fungal Polysaccharides*/classification
Fungal Polysaccharides*/therapeutic use
Immunologic Factors*/chemistry
Immunologic Factors*/classification
Immunologic Factors*/therapeutic use
Agaricales/*chemistry
COVID-19/*drug therapy
SARS-CoV-2/*immunology
COVID-19/immunology ; COVID-19/prevention & control ; Gastrointestinal Microbiome/drug effects ; Gastrointestinal Microbiome/immunology ; Humans
SCR Protocol :
COVID-19 drug treatment
Czasopismo naukowe
Tytuł :
Immunomodulatory and Anti-inflammatory Effects of Asiatic Acid in a DNCB-Induced Atopic Dermatitis Animal Model.
Autorzy :
Moon GH; Department of Food and Nutrition, KC University, Seoul 07661, Korea.; Department of Food Science and Technology, Seoul National University of Science & Technology, Seoul 01811, Korea.
Lee Y; Department of Food and Nutrition, KC University, Seoul 07661, Korea.; Department of Food Science and Technology, Seoul National University of Science & Technology, Seoul 01811, Korea.
Kim EK; Department of Food Science and Nutrition, Dong-A University, Busan 49315, Korea.; Center for Silver-targeted Biomaterials, Brain Busan 21 Plus program, Dong-A University, Busan 49315, Korea.
Chung KH; Department of Food Science and Technology, Seoul National University of Science & Technology, Seoul 01811, Korea.
Lee KJ; Department of H-LAC, Daejeon University, Daejeon 34520, Korea.
An JH; Department of Food and Nutrition, KC University, Seoul 07661, Korea.
Pokaż więcej
Źródło :
Nutrients [Nutrients] 2021 Jul 17; Vol. 13 (7). Date of Electronic Publication: 2021 Jul 17.
Typ publikacji :
Journal Article
MeSH Terms :
Anti-Inflammatory Agents, Non-Steroidal/*pharmacology
Cytokines/*metabolism
Dermatitis, Atopic/*drug therapy
Immunologic Factors/*pharmacology
Pentacyclic Triterpenes/*pharmacology
Animals ; Anti-Inflammatory Agents, Non-Steroidal/administration & dosage ; Anti-Inflammatory Agents, Non-Steroidal/therapeutic use ; Cell Line ; Cell Survival ; Collagen/analysis ; Cytokines/genetics ; Dermatitis, Atopic/immunology ; Dermatitis, Atopic/pathology ; Dermis/pathology ; Dinitrochlorobenzene ; Disease Models, Animal ; Epidermis/pathology ; Female ; Gene Expression Regulation ; Humans ; Immunologic Factors/administration & dosage ; Immunologic Factors/therapeutic use ; Immunomodulation ; Lymphoid Tissue/pathology ; MAP Kinase Signaling System/drug effects ; Mast Cells ; Mice ; Mice, Inbred BALB C ; NF-kappa B/metabolism ; Organ Size/drug effects ; Pentacyclic Triterpenes/therapeutic use ; Proto-Oncogene Proteins c-akt/metabolism ; Signal Transduction/drug effects
Czasopismo naukowe
Tytuł :
The impact of caseinate oligochitosan-glycation by transglutaminase on amino acid compositions and immune-promoting activity in BALB/c mice of the tryptic caseinate hydrolysate.
Autorzy :
Shi J; School of Biology and Food Engineering, Guangdong University of Petrochemical Technology, 525000 Maoming, PR China; Key Laboratory of Dairy Science, Ministry of Education, Northeast Agricultural University, 150030 Harbin, PR China.
Zhang Q; School of Biology and Food Engineering, Guangdong University of Petrochemical Technology, 525000 Maoming, PR China.
Zhao XH; School of Biology and Food Engineering, Guangdong University of Petrochemical Technology, 525000 Maoming, PR China; Key Laboratory of Dairy Science, Ministry of Education, Northeast Agricultural University, 150030 Harbin, PR China; Maoming Branch, Guangdong Laboratory for Lingnan Modern Agriculture, Guangdong University of Petrochemical Technology, 525000 Maoming, PR China. Electronic address: .
Wang L; School of Biology and Food Engineering, Guangdong University of Petrochemical Technology, 525000 Maoming, PR China. Electronic address: .
Pokaż więcej
Źródło :
Food chemistry [Food Chem] 2021 Jul 15; Vol. 350, pp. 129302. Date of Electronic Publication: 2021 Feb 16.
Typ publikacji :
Journal Article
MeSH Terms :
Caseins/*chemistry
Caseins/*pharmacology
Chitin/*analogs & derivatives
Immunologic Factors/*chemistry
Immunologic Factors/*pharmacology
Transglutaminases/*metabolism
Animals ; Apoptosis/drug effects ; Caseins/metabolism ; Chitin/chemistry ; Glycosylation ; Hydrolysis ; Immunologic Factors/metabolism ; Killer Cells, Natural/cytology ; Killer Cells, Natural/drug effects ; Killer Cells, Natural/immunology ; Mice ; Mice, Inbred BALB C ; Structure-Activity Relationship
Czasopismo naukowe
Tytuł :
A neutral polysaccharide with a triple helix structure from ginger: Characterization and immunomodulatory activity.
Autorzy :
Yang X; Key Laboratory of Food Processing Technology and Quality Control in Shandong Province, College of Food Science and Engineering, Shandong Agricultural University, Tai'an, China.
Wei S; Shandong Foreign Trade Vocational College, Tai'an 271018, China.
Lu X; Key Laboratory of Food Processing Technology and Quality Control in Shandong Province, College of Food Science and Engineering, Shandong Agricultural University, Tai'an, China.
Qiao X; Key Laboratory of Food Processing Technology and Quality Control in Shandong Province, College of Food Science and Engineering, Shandong Agricultural University, Tai'an, China. Electronic address: .
Simal-Gandara J; Nutrition and Bromatology Group, Department of Analytical Chemistry and Food Science, Faculty of Food Science and Technology, University of Vigo - Ourense Campus, E-32004 Ourense, Spain. Electronic address: .
Capanoglu E; Department of Food Engineering, Faculty of Chemical and Metallurgical Engineering, Istanbul Technical University, 34469 Maslak, Istanbul, Turkey. Electronic address: .
Woźniak Ł; Department of Fruit and Vegetable Product Technology, Institute of Agricultural and Food Biotechnology, 36 Rakowiecka Street, 02532 Warsaw, Poland. Electronic address: .
Zou L; Key Laboratory of Coarse Cereal Processing, Ministry of Agriculture and Rural Affairs, Chengdu University, Chengdu 610106, China. Electronic address: .
Cao H; College of Food Science and Technology, Guangdong Ocean University, Zhanjiang 524088, China. Electronic address: .
Xiao J; Nutrition and Bromatology Group, Department of Analytical Chemistry and Food Science, Faculty of Food Science and Technology, University of Vigo - Ourense Campus, E-32004 Ourense, Spain; College of Food Science and Technology, Guangdong Ocean University, Zhanjiang 524088, China; International Research Center for Food Nutrition and Safety, Jiangsu University, Zhenjiang 212013, China. Electronic address: .
Tang X; Key Laboratory of Food Processing Technology and Quality Control in Shandong Province, College of Food Science and Engineering, Shandong Agricultural University, Tai'an, China. Electronic address: .
Li N; Key Laboratory of Food Processing Technology and Quality Control in Shandong Province, College of Food Science and Engineering, Shandong Agricultural University, Tai'an, China. Electronic address: .
Pokaż więcej
Źródło :
Food chemistry [Food Chem] 2021 Jul 15; Vol. 350, pp. 129261. Date of Electronic Publication: 2021 Feb 10.
Typ publikacji :
Journal Article
MeSH Terms :
Ginger/*chemistry
Immunologic Factors/*chemistry
Immunologic Factors/*pharmacology
Polysaccharides/*chemistry
Polysaccharides/*pharmacology
Animals ; Immunologic Factors/analysis ; Macrophages/drug effects ; Macrophages/immunology ; Methylation ; Mice ; Molecular Weight ; Polysaccharides/analysis ; RAW 264.7 Cells
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies